Landfar Bio-medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022
Cash & Equivalents	183.37	346.77	207.36	493.81	218.15	153
Trading Asset Securities	120	-	0.61	1.72	1.69	0.5
Cash & Short-Term Investments	303.37	346.77	207.97	495.53	219.83	153.51
Cash Growth	76.53%	66.74%	-58.03%	125.41%	43.21%	126.76%
Accounts Receivable	350.59	320.48	139.58	123.22	158.76	197.92
Other Receivables	17.65	18.02	13.62	19.35	27.67	8.82
Receivables	368.24	338.5	153.2	142.57	186.43	206.74
Inventory	48.54	18.67	34.06	10.66	4.5	10.64
Prepaid Expenses	-	-	0.16	0.07	0.03	0.57
Other Current Assets	46.9	34.99	6.51	6.02	5.44	145.17
Total Current Assets	767.06	738.92	401.9	654.85	416.24	516.62
Property, Plant & Equipment	169.08	170.22	26.05	28.06	35.93	35.85
Long-Term Investments	-	-	100	5.42	5.48	5.98
Goodwill	6.23	6.23	1.98	1.98	8.44	8.44
Other Intangible Assets	55.55	55.81	1.86	0.44	0.36	0.22
Long-Term Accounts Receivable	-	-	0.03	0.04	0.06	0.07
Long-Term Deferred Tax Assets	8.71	8.71	1.92	1.11	0.6	1.05
Long-Term Deferred Charges	9.8	10.83	73.75	79.48	85.67	89.58
Other Long-Term Assets	-	1.01	0.67	-	0.58	1.44
Total Assets	1,016	991.73	608.17	771.38	553.37	659.25
Accounts Payable	14.4	14.72	84.47	82.21	82.03	89.56
Accrued Expenses	3.95	7.74	8.03	9.01	8.61	6.17
Short-Term Debt	278.41	270.25	-	187.71	218.73	293.06
Current Portion of Long-Term Debt	13.1	14.8	1	-	-	-
Current Portion of Leases	-	-	3.61	3.16	2.81	2.35
Current Income Taxes Payable	4.35	15.36	2.58	1.62	7.19	4.88
Current Unearned Revenue	206.83	201.45	185.18	151.41	119.74	123.84
Other Current Liabilities	33.72	20.84	20.61	17.28	16.04	9.14
Total Current Liabilities	554.77	545.16	305.47	452.4	455.15	529
Long-Term Debt	52.95	52.95	9	-	-	-
Long-Term Leases	5.23	3.24	10.45	13	14.79	16.89
Long-Term Unearned Revenue	27.3	26.64	1.1	1.06	1.83	1.4
Long-Term Deferred Tax Liabilities	6.24	6.24	0.15	0.25	0.41	0.64
Other Long-Term Liabilities	0.86	-	-	-	1	1
Total Liabilities	647.35	634.22	326.17	466.71	473.18	548.93
Common Stock	330.02	330.02	330.02	330.02	311.57	311.57
Additional Paid-In Capital	423.3	423.3	423.47	423.47	170.82	160.99
Retained Earnings	-476.47	-487.57	-516.4	-496.55	-468.38	-455.92
Total Common Equity	276.85	265.75	237.1	256.94	14.01	16.64
Minority Interest	92.22	91.76	44.9	47.73	66.18	93.68
Shareholders' Equity	369.07	357.51	282	304.67	80.19	110.32
Total Liabilities & Equity	1,016	991.73	608.17	771.38	553.37	659.25
Total Debt	349.68	341.24	24.06	203.87	236.33	312.29
Net Cash (Debt)	-46.31	5.53	183.91	291.66	-16.5	-158.79
Net Cash Growth	-	-97.00%	-36.94%	-	-	-
Net Cash Per Share	-0.14	0.02	0.56	0.93	-0.05	-0.50
Filing Date Shares Outstanding	330.38	294.04	330.02	330.02	311.57	311.57
Total Common Shares Outstanding	330.38	294.04	330.02	330.02	311.57	311.57
Working Capital	212.29	193.76	96.43	202.45	-38.92	-12.38
Book Value Per Share	0.84	0.90	0.72	0.78	0.04	0.05
Tangible Book Value	215.08	203.71	233.25	254.52	5.21	7.98
Tangible Book Value Per Share	0.65	0.69	0.71	0.77	0.02	0.03
Buildings	-	-	-	-	12.94	12.94
Machinery	-	-	25.09	23.4	22.39	16.85
Construction In Progress	-	-	-	-	-	1.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.